Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis

Over the past decade, the prevalence of infections involving methicillin-resistant Staphylococcus aureus (MRSA) in patients with cystic fibrosis (CF) has increased significantly. Tedizolid (TZD) demonstrates excellent activity against MRSA and a favorable safety profile. The pharmacokinetics of seve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Park, A young J., Wang, Joshua, Jayne, Jordanna, Fukushima, Lynn, Rao, Adupa P., D'Argenio, David Z., Beringer, Paul M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2018
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125567/
https://ncbi.nlm.nih.gov/pubmed/29914949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00550-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars